SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    International Early Lung Cancer Action Program Investigators; Henschke CI,Yankelevitz DF,Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355: 17631771.
  • 2
    American Cancer Society, Cancer Facts and Figures 2007. Atlanta: American Cancer Society. Available at URL: http://www.cancer.org Accessed on May 14, 2008.
  • 3
    US Preventive Services Task Force; Humphrey LL,Teutsch S,Johnson M. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the US Preventive Services Task Force. Ann Intern Med. 2004; 140: 740753.
  • 4
    van Iersel CA,de Koning HJ,Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer. 2007; 120: 868874.
  • 5
    National Cancer Institute. National Lung Screening Trial. Available at URL: http://www.cancer.gov/nlst Accessed on May 4, 2007.
  • 6
    Ramsey SD,McIntosh M,Etzioni R,Urban N. Simulation modeling of outcomes and cost effectiveness. Hematol Oncol Clin North Am. 2000; 14: 925938.
  • 7
    Weinstein MC. Recent developments in decision-analytic modelling for economic evaluation. Pharmacoeconomics. 2006; 24: 10431053.
  • 8
    Knudsen AB,McMahon PM,Gazelle GS. Use of modeling to evaluate the cost-effectiveness of cancer screening programs. J Clin Oncol. 2007; 25: 203208.
  • 9
    Robertson JIS. A critique of hypertension treatment trials and of their evaluation. J Eval Clin Pract. 2001; 7: 149164.
  • 10
    Weinstein MC,Stason WB. Economic considerations in the management of mild hypertension. Ann N Y Acad Sci. 1978; 304: 424436.
  • 11
    [No authors listed.] The Australian therapeutic trial in mild hypertension. Report by the Management Committee. Lancet 1980; 1: 12611267.
  • 12
    Russell LB. Modelling for cost-effectiveness analysis. Stat Med. 1999; 18: 32353244.
  • 13
    McMahon PM,Kong CY,Johnson BE, et al. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology. 2008; 248: 278287.
  • 14
    McMahon PM,Kong CY,Gazelle GS. Model profiler of the MGH-ITA Lung Cancer Policy Model. Available at: CISNET http://cisnet.cancer.gov/profiles/
  • 15
    Mahadevia P,Fleisher L,Frick K,Eng J,Goodman S,Powe N. Lung cancer screening with helical computed tomography in older adult smokers. JAMA. 2003; 289: 313322.
  • 16
    Wisnivesky J,Mushlin A,Sicherman N,Henschke C. The cost-effectiveness of low-dose CT screening for lung cancer. Chest. 2003; 124: 614621.
  • 17
    Feuer EJ,Etzioni R,Cronin KA,Mariotto A. The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing. Stat Methods Med Res. 2004; 13: 421442.
  • 18
    Kramer BS,Gohagan JK,Prorok PC. Cancer screening: theory and practice. In: ChesonBD, ed. Basic and Clinical Oncology, vol. 18. New York: Marcel Dekker; 1999.
  • 19
    Henschke C,McCauley D,Yankelevitz D, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999; 354: 99105.
  • 20
    Swensen SJ,Jett JR,Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002; 165: 508513.
  • 21
    Diederich S,Wormanns D,Semik M, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology. 2002; 222: 773781.
  • 22
    Gohagan J,Marcus P,Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004; 126: 114121.
  • 23
    Blanchon T,Brechot J,Grenier P, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007; 58: 5058.
  • 24
    McMahon PM,Zaslavsky AM,Weinstein MC,Kuntz KM,Weeks JC,Gazelle GS. Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making. 2006; 26: 497511.
  • 25
    National Center for Health Statistics. National Health Interview Survey. Available at URL: http://www.cdc.gov/nchs/nhis.htm Accessed on October 20, 2008.
  • 26
    US Department of Health and Human Services, National Center for Health Statistics. The National Health and Nutrition Examination Survey III Data file 1988-1994.Public Use Data file Series 11. Hyattsville, MD: Centers for Disease Control and Prevention; 1997.
  • 27
    US Bureau of the Census. 1990 Census of Population and Housing, 1990 Summary Tape File 1 (STF 1) - 100- Percent data, ed. American FactFinder; 1990.. Available at URL: http://factfinder.census.gov/metadoc/1990stf/td.pdf Accessed on October 20, 2008.
  • 28
    [No authors listed.] National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Database: Incidence - SEER 9 Regs Public-Use, Nov 2002 Sub (1973-2000), Software: Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) ver. 5.3.0. Bethesda, Maryland: Surveillance, Epidemiology, and End Results (SEER) Program; 2003.
  • 29
    [No authors listed.] Centers for Disease Control. Smoking Cessation During Previous Year Among Adults—United States, 1990 and 1991. MMWR. 1993; 42: 504507.
  • 30
    [No authors listed.] The Commit Research Group. Community Intervention Trial for Smoking Cessation (COMMIT): II. Changes in adult cigarette smoking prevalence. Am J Public Health. 1995; 85: 193200.
  • 31
    Thun M,Henley S,Burns D,Jemal A,Shanks T,Calle E. Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst. 2006; 98: 691699.
  • 32
    Wakelee HA,Chang ET,Gomez SL, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007; 25: 472478.
  • 33
    Silvestri GA,Nietert PJ,Zoller J,Carter C,Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007; 62: 126130.
  • 34
    Schwartz LM,Woloshin S,Fowler FJJr.,Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004; 291: 7178.
  • 35
    Montes U,Seijo LM,Campo A,Alcaide AB,Bastarrika G,Zulueta JJ. Factors determining early adherence to a lung cancer screening protocol. Eur Respir J. 2007; 30: 532537.
  • 36
    Gohagan JK,Marcus PM,Fagerstrom RM, et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005; 47: 915.
  • 37
    Swensen SJ,Jett JR,Hartman TE, et al. CT screening for lung cancer: Five-year prospective experience. Radiology. 2005; 235: 259265.
  • 38
    Law AM,Kelton WD. Simulation Modeling and Analysis, 3rd ed. Columbus, OH: McGraw-Hill; 2000.
  • 39
    Wright JC,Weinstein MC. Gains in life expectancy from medical interventions—standardizing data on outcomes. N Engl J Med. 1998; 339: 380386.
  • 40
    Frazier A,Colditz G,Fuchs C,Kuntz K. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000; 284: 19541961.
  • 41
    Schrag D,Kuntz KM,Garber JE,Weeks JC. Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA. 2000; 283: 617624.
  • 42
    Lee JM,Kopans DB,McMahon PM, et al. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging–Markov Monte Carlo decision analysis. Radiology. 2008; 246: 763771.
  • 43
    Townsend CO,Clark MM,Jett JR, et al. Relation between smoking cessation and receiving results from 3 annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005; 103: 21542162.
  • 44
    Ostroff JS,Buckshee N,Mancuso CA,Yankelevitz DF,Henschke C. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001; 33: 613621.
  • 45
    Bach PB. Overdiagnosis in lung cancer: different perspectives, definitions, implications. Thorax. 2008; 63: 298300.
  • 46
    Chien CR,Chen TH. Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. Int J Cancer. 2008; 122: 25942599.
  • 47
    Bach PB,Jett JR,Pastorino U,Tockman MS,Swensen SJ,Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007; 297: 953961.
  • 48
    [No authors listed.] Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. In: US DHHS, ed. Atlanta, GA: Centers for Disease Control and Prevention; 2006.
  • 49
    [No authors listed.] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology; 2000. Available at URL: http://www.nccn.org accessed October 20, 2008.
  • 50
    Ford ME,Havstad SL,Flickinger L,Johnson CC. Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 2003; 12: 2833.
  • 51
    Brewer NT,Salz T,Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med. 2007; 146: 502510.
  • 52
    Oreskes N,Shrader-Frechette K,Belitz K. Verification, validation, and confirmation of numerical models in the earth sciences. Science. 1994; 263: 641646.